Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials
Objective To investigate the clinical efficacy and toxicity of Pemetrexed versus Gefitinib as second-line treatment for advanced non-small cell lung cancer (NSCLC).
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2019-12-01
|
| Series: | Pteridines |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/pteridines-2019-0022 |
| _version_ | 1830178880768442368 |
|---|---|
| author | Wang Huiyu Zhang Zunjing Liu Feng Zhou Miaoying Lv Handi |
| author_facet | Wang Huiyu Zhang Zunjing Liu Feng Zhou Miaoying Lv Handi |
| author_sort | Wang Huiyu |
| collection | DOAJ |
| description | Objective To investigate the clinical efficacy and toxicity of Pemetrexed versus Gefitinib as second-line treatment for advanced non-small cell lung cancer (NSCLC). |
| first_indexed | 2024-12-17T19:49:19Z |
| format | Article |
| id | doaj.art-8202f2d5911545b4898f8d58e49d9254 |
| institution | Directory Open Access Journal |
| issn | 0933-4807 2195-4720 |
| language | English |
| last_indexed | 2024-12-17T19:49:19Z |
| publishDate | 2019-12-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Pteridines |
| spelling | doaj.art-8202f2d5911545b4898f8d58e49d92542022-12-21T21:34:46ZengDe GruyterPteridines0933-48072195-47202019-12-0130117117610.1515/pteridines-2019-0022pteridines-2019-0022Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled TrialsWang Huiyu0Zhang Zunjing1Liu Feng2Zhou Miaoying3Lv Handi4Department of Pharmacy, Traditional Chinese Medicine Hospital of Lishui, Zhejiang Province, 323000 PR ChinaDepartment of Infection, Traditional Chinese Medicine Hospital of Lishui, Zhejiang Province, 323000 PR ChinaDepartment of Pharmacy, Traditional Chinese Medicine Hospital of Lishui, Zhejiang Province, 323000 PR ChinaDepartment of Pharmacy, Longquan People’s Hospital, Zhejiang Province, 323700 PR ChinaDepartment of Respiratory, Zhuji Affiliated Hospital of Shaoxing University, Zhejiang Province 311800 PR ChinaObjective To investigate the clinical efficacy and toxicity of Pemetrexed versus Gefitinib as second-line treatment for advanced non-small cell lung cancer (NSCLC).https://doi.org/10.1515/pteridines-2019-0022pemetrexedgefitinibnon-small cell lung cancermeta-analysis |
| spellingShingle | Wang Huiyu Zhang Zunjing Liu Feng Zhou Miaoying Lv Handi Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials Pteridines pemetrexed gefitinib non-small cell lung cancer meta-analysis |
| title | Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials |
| title_full | Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials |
| title_fullStr | Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials |
| title_full_unstemmed | Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials |
| title_short | Pemetrexed versus Gefitinib as Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Meta-analysis Based on Randomized Controlled Trials |
| title_sort | pemetrexed versus gefitinib as second line treatment for advanced non small cell lung cancer a meta analysis based on randomized controlled trials |
| topic | pemetrexed gefitinib non-small cell lung cancer meta-analysis |
| url | https://doi.org/10.1515/pteridines-2019-0022 |
| work_keys_str_mv | AT wanghuiyu pemetrexedversusgefitinibassecondlinetreatmentforadvancednonsmallcelllungcancerametaanalysisbasedonrandomizedcontrolledtrials AT zhangzunjing pemetrexedversusgefitinibassecondlinetreatmentforadvancednonsmallcelllungcancerametaanalysisbasedonrandomizedcontrolledtrials AT liufeng pemetrexedversusgefitinibassecondlinetreatmentforadvancednonsmallcelllungcancerametaanalysisbasedonrandomizedcontrolledtrials AT zhoumiaoying pemetrexedversusgefitinibassecondlinetreatmentforadvancednonsmallcelllungcancerametaanalysisbasedonrandomizedcontrolledtrials AT lvhandi pemetrexedversusgefitinibassecondlinetreatmentforadvancednonsmallcelllungcancerametaanalysisbasedonrandomizedcontrolledtrials |